Luomalla maksuttoman Inderes-tilin, pääset käsiksi Inderesin analyysiin, voit tilata suositun aamukatsauksen ja seurata sinua kiinnostavia yhtiöitä sekä keskusteluita.
Onko sinulla jo Inderes-tili?
Follow this company like 1345 other investors.
Redeye is encouraged by Azelio's progress in its most important key market. The deal itself is small but has significant strategic value, taking the company one step closer to a commercial launch in the USA.
Redeye resumes coverage of Azelio following its introduction of new operational targets for the coming years. Most notably, the targets are now related to making deals rather than establishing a production capacity.
Until this point, the progress of signing firm deals has been below our expectations and we expect to make significant downward estimate revisions for the coming years.
Redeye comments on this morning’s press release from Azelio, where it was communicated that leading international certification body DNV validates Azelio’s TES.POD.
Redeye comments on Azelio’s Q3 report which held no surprises, as expected.
Redeye comments on today order received from South African farming company Wee Bee. The order is for 8 TES.PODs for a total order value of SEK 11m over 15 years.
Redeye comments on today’s press release from Azelio, where it announced it had initiated production of the TES.POD in its factory in Uddevalla.
Redeye comments on Azelio's Q2 report, which held no surprises. The report came one day after Azelio announced its largest order to date, and all focus is on getting serial production ready by the end of September, which is going according to plan.
Redeye comments on Azelio’s largest order to date, corresponding to 20 TES.PODs for delivery to Engazaat Development (Egypt) in December 2021.
Redeye comments on the hefty share price movement caused by an article published by Swedish news magazine Dagens Industri (DI).